Gabrion, Aurélie <br/><br/>
Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease.  [electronic resource] 

 -  The Journal of allergy and clinical immunology  May 2017 
 - 1641-1649.e6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-6825 
<br/><br/><label>Standard No.: </label>10.1016/j.jaci.2016.08.033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>CD4-Positive T-Lymphocytes--drug effects<br/>Child<br/>Child, Preschool<br/>Cytokines--immunology<br/>Female<br/>Granulomatous Disease, Chronic--immunology<br/>Humans<br/>Immunosuppressive Agents--pharmacology<br/>Infant<br/>Inflammation--immunology<br/>Interleukin 1 Receptor Antagonist Protein--pharmacology<br/>Male<br/>Middle Aged<br/>Monocytes--drug effects<br/>Phagocytes--drug effects<br/>Sirolimus--pharmacology<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Young Adult